Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06887894

Biomarkers and Unstable Carotid Plaque

This prospective study investigated associations between circulating miRNAs and symptomatic and asymptomatic ICAS, carotid plaque morphology and future cardiovascular events.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Fondazione Policlinico Universitario A. Gemelli IRCCS

Roma, RM, 00167, Italy

Location status: Recruiting

Location contact

Giovanni Tinelli

CONTACT

[email protected]

0039 0630157205

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Presence of significant internal carotid artery stenosis referred to carotid artery endarterectomy.
  • Age>18 years

Exclusion criteria

  • Presence of significant internal carotid artery stenosis referred to carotid artery stenting

Treatment and study plan

carotid endarterectomy

Procedure

Carotid endarterectomy, plaque histological analysis and miRNA expression

Primary outcomes

  1. miRNA levels

    Time frame: 30 days

    miRNA levels and plaque vulnerability

Sponsors and collaborators

Lead sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Other

Registry information

Official study title

EVALUATION OF NEW BIOMARKERS IN THE IDENTIFICATION OF UNSTABLE CAROTID PLAQUE

Important dates

Study start
2019
Primary completion
2025
Study completion
2027
First posted
Mar 20, 2025
Registry last updated
Mar 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.